Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Saldanha CE, Lubinski J, Martin C, Nagashunmugam T, Wang L, van Der Keyl H, Tal-Singer R, Friedman HM.

J Virol. 2000 Aug;74(15):6712-9.

2.

Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.

Nagashunmugam T, Malamud D, Davis C, Abrams WR, Friedman HM.

J Infect Dis. 1998 Dec;178(6):1635-41.

PMID:
9815215
3.

Construction of attenuated HIV-1 accessory gene immunization cassettes.

Ayyavoo V, Nagashunmugam T, Phung MT, Buckner C, Kudckodkar S, Le P, Reddy PJ, Santiago L, Patel M, Tea L, Weiner DB.

Vaccine. 1998 Nov;16(19):1872-9.

PMID:
9795395
4.

Detection of human immunodeficiency virus antibodies in oral fluids.

Hodinka RL, Nagashunmugam T, Malamud D.

Clin Diagn Lab Immunol. 1998 Jul;5(4):419-26. Review. No abstract available.

5.

Viral interference with antibody and complement.

Lubinski J, Nagashunmugam T, Friedman HM.

Semin Cell Dev Biol. 1998 Jun;9(3):329-37. Review.

PMID:
9665870
6.

Submandibular salivary proteases: lack of a role in anti-HIV activity.

Kennedy S, Davis C, Abrams WR, Billings PC, Nagashunmugam T, Friedman H, Malamud D.

J Dent Res. 1998 Jul;77(7):1515-9.

PMID:
9663436
7.

In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Nagashunmugam T, Lubinski J, Wang L, Goldstein LT, Weeks BS, Sundaresan P, Kang EH, Dubin G, Friedman HM.

J Virol. 1998 Jul;72(7):5351-9.

8.

Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes.

Ayyavoo V, Nagashunmugam T, Boyer J, Mahalingam S, Fernandes LS, Le P, Lin J, Nguyen C, Chattargoon M, Goedert JJ, Friedman H, Weiner DB.

AIDS. 1997 Oct;11(12):1433-44.

PMID:
9342065
9.

HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro.

Ayyavoo V, Mahalingam S, Rafaeli Y, Kudchodkar S, Chang D, Nagashunmugam T, Williams WV, Weiner DB.

J Leukoc Biol. 1997 Jul;62(1):93-9. Review.

PMID:
9225999
10.

The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains.

Weeks BS, Sundaresan P, Nagashunmugam T, Kang E, Friedman HM.

Biochem Biophys Res Commun. 1997 Jun 9;235(1):31-5.

PMID:
9196030
11.

Inhibition of HIV infectivity by human saliva.

Malamud D, Nagashunmugam T, Davis C, Kennedy S, Abrams WR, Kream R, Friedman HM.

Oral Dis. 1997 May;3 Suppl 1:S58-63.

PMID:
9456659
12.

Human submandibular saliva specifically inhibits HIV type 1.

Nagashunmugam T, Friedman HM, Davis C, Kennedy S, Goldstein LT, Malamud D.

AIDS Res Hum Retroviruses. 1997 Mar 20;13(5):371-6.

PMID:
9075477
13.

HIV-1 viral protein R (Vpr) as a regulator of the target cell.

Ayyavoo V, Rafaeli Y, Nagashunmugam T, Mahalingham S, Phung MT, Hamam A, Williams WV, Weiner DB.

Psychoneuroendocrinology. 1997;22 Suppl 1:S41-9. Review.

PMID:
9264146
14.

Mapping regions of herpes simplex virus type 1 glycoprotein I required for formation of the viral Fc receptor for monomeric IgG.

Basu S, Dubin G, Nagashunmugam T, Basu M, Goldstein LT, Wang L, Weeks B, Friedman HM.

J Immunol. 1997 Jan 1;158(1):209-15.

PMID:
8977192
15.

Differential production of interleukin 10 during human immunodeficiency virus infection.

Chehimi J, Ma X, Chouaib S, Zyad A, Nagashunmugam T, Wojcik L, Chehimi S, Nissim L, Frank I.

AIDS Res Hum Retroviruses. 1996 Aug 10;12(12):1141-9.

PMID:
8844018
16.
17.

Structure-function studies of HIV-1: influence of long terminal repeat U3 region sequences on virus production.

Velpandi A, Nagashunmugam T, Otsuka T, Cartas M, Srinivasan A.

DNA Cell Biol. 1992 Jun;11(5):369-76.

PMID:
1351391
18.

Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity.

Nagashunmugam T, Velpandi A, Goldsmith CS, Zaki SR, Kalyanaraman VS, Srinivasan A.

Proc Natl Acad Sci U S A. 1992 May 1;89(9):4114-8.

19.

Analysis of the viral determinants underlying replication kinetics and cellular tropism of human immunodeficiency virus.

Nagashunmugam T, Velpandi A, Otsuka T, Cartas M, Srinivasan A.

Pathobiology. 1992;60(4):234-45.

PMID:
1388721
20.

Structure and expression of the beta-platelet-derived growth factor receptor gene in human tumor cell lines.

Malik R, Gope M, Womer RB, Nagashunmugam T, Margolin JF, Basu A, Scher CD.

Cancer Res. 1991 Oct 15;51(20):5626-31.

21.

Generation of hybrid human immunodeficiency virus utilizing the cotransfection method and analysis of cellular tropism.

Velpandi A, Nagashunmugam T, Murthy S, Cartas M, Monken C, Srinivasan A.

J Virol. 1991 Sep;65(9):4847-52.

23.

Partial purification of a recombinase activity from human placenta and assay of recombination using rec-blot.

Jeyaseelan R, Nagashunmugam T, Shanmugam G.

Biochem Int. 1987 Oct;15(4):735-44.

PMID:
3435537
24.

S phase mouse embryo fibroblasts secrete varying amounts of a 45,000 dalton protein.

Nagashunmugam T, Shanmugam G.

Cell Biol Int Rep. 1987 Mar;11(3):147-55.

PMID:
3581177

Supplemental Content

Loading ...
Support Center